Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1858 ARTÍCULOS , VIENDO DEL 451 AL 465

The molecular anatomy and functions of the choroid plexus in healthy and diseased brain

Kratzer I, Ek J, Stolp H.

Biochim Biophys Acta Biomembr. 2020 Nov 1;1862(11):183430. doi: 10.1016/j.bbamem.2020.183430. Epub 2020 Aug 1.

P38α MAPK Signaling-A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease

Germann UA, Alam JJ.

Int J Mol Sci. 2020 Jul 31;21(15):5485. doi: 10.3390/ijms21155485.

Biosynthesis and signalling functions of central and peripheral nervous system neurosteroids in health and disease

Lloyd-Evans E, Waller-Evans H.

Essays Biochem. 2020 Sep 23;64(3):591-606. doi: 10.1042/EBC20200043.

Sarcopenia in female patients with Alzheimer's disease are more likely to have lower levels of haemoglobin and 25-hydroxyvitamin D

Lee HN, Chang YS, Wu YH, Wu CH, Wang CJ.

Psychogeriatrics. 2020 Nov;20(6):858-864. doi: 10.1111/psyg.12593. Epub 2020 Aug 6.

Anti-amyloid-β protein agents for the treatment of Alzheimer's disease: an update on emerging drugs

Lozupone M, Solfrizzi V, D'Urso F, Di Gioia I, Sardone R, Dibello V, Stallone R, Liguori A, Ciritella C, Daniele A, Bellomo A, Seripa D, Panza F.

Expert Opin Emerg Drugs. 2020 Sep;25(3):319-335. doi: 10.1080/14728214.2020.1808621. Epub 2020 Aug 20.

Synergy between amyloid-β and tau in Alzheimer's disease

Busche MA, Hyman BT.

Nat Neurosci. 2020 Oct;23(10):1183-1193. doi: 10.1038/s41593-020-0687-6. Epub 2020 Aug 10.

Potential cost savings for selected non-pharmacological treatment strategies for patients with Alzheimer's disease in Finland

Rosenvall A, Sääksvuori L, Finne-Soveri H, Linnosmaa I, Malmivaara A.

J Rehabil Med. 2020 Sep 30;52(9):jrm00106. doi: 10.2340/16501977-2722.

[Emma Wilson Mooers (1858-1911): the neuropathologist at Aloys Alzheimer's side]

Förstl H.

Nervenarzt. 2020 Dec;91(12):1146-1148. doi: 10.1007/s00115-020-00979-w.

Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease

Huang Z, Wong LW, Su Y, Huang X, Wang N, Chen H, Yi C.

Front Neuroendocrinol. 2020 Oct;59:100857. doi: 10.1016/j.yfrne.2020.100857. Epub 2020 Aug 8.

Role of tau protein in Alzheimer's disease: The prime pathological player

Muralidar S, Ambi SV, Sekaran S, Thirumalai D, Palaniappan B.

Int J Biol Macromol. 2020 Nov 15;163:1599-1617. doi: 10.1016/j.ijbiomac.2020.07.327. Epub 2020 Aug 9.

The MMP-2/TIMP-2 System in Alzheimer Disease

Wang H, Huang L, Wu L, Lan J, Feng X, Li P, Peng Y.

CNS Neurol Disord Drug Targets. 2020;19(6):402-416. doi: 10.2174/1871527319666200812223007.

Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval

Tolar M, Abushakra S, Hey JA, Porsteinsson A, Sabbagh M.

Alzheimers Res Ther. 2020 Aug 12;12(1):95. doi: 10.1186/s13195-020-00663-w.

Immunological Features of Non-neuronal Brain Cells: Implications for Alzheimer's Disease Immunotherapy

Castellani G, Schwartz M.

Trends Immunol. 2020 Sep;41(9):794-804. doi: 10.1016/j.it.2020.07.005. Epub 2020 Aug 13.

A Comparative Study on 5hmC Targeting Regulation of Neurons in AD Mice by Several Natural Compounds

Cao D, Jiang D, Zhou D, Yu H, Li J.

Biomed Res Int. 2020 Aug 5;2020:5016706. doi: 10.1155/2020/5016706. eCollection 2020.

Animal Models of Alzheimer's Disease Should Be Controlled for Roseolovirus

Denner J, Tanzi R, Jacobson S.

J Alzheimers Dis. 2020;77(2):543-545. doi: 10.3233/JAD-200591.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias